XML 26 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2018
Equity [Abstract]  
Summary of Outstanding Warrants

The following table summarizes information of outstanding warrants issued to investors and consultants in exchange for their services as of June 30, 2018:

 

    Warrants     Warrant Term     Exercise Price     Exercisable  
Investors – Class A Warrants     571,429       August 2019     $ 0.14       571,429  
Investors – Class B Warrants     571,429       August 2019     $ 0.14       571,429  
Alimi Ahmed - Class E Warrants     900,000       (1 )   $ 0.0001       900,000  
Investors – Class F Warrants     27,692,855       January 2019 -April 2019     $ 0.14       27,697,855  
Investors – Class G Warrants     27,692,855       January 2019 -April 2019     $ 0.28       27,697,855  
Investors - Class H Warrants     200,000       January 2020     $ 0.14       200,000  

 

(1) During 2015, a total of 2,700,000 Class E Warrants were issued by the Company to Lior Wayn pursuant to the terms of the Share Exchange Agreement and were exercisable in three equal tranches of 900,000 Shares each (the “Tranches”) at an exercise price of $0.0001 per share of the Company’s common stock, subject to and within 45 days of the Company achieving the milestones defined in the Share Exchange Agreement. On December 16, 2016, the Company terminated Lior Wayn’s employment agreements with the Company and Emerald Israel, and removed him as an executive officer and director. During 2017, Mr. Wayn transferred, sold and assigned his 5,212,878 shares of the Company’s common stock and 900,000 Class E Warrants that were fully-vested to an entity controlled by Mr. Alimi Ahmed, then a member of the Company’s Board of Directors. Effective as of December 31, 2016, the remaining 1,800,000 Class E Warrants that had been issued to Mr. Wayn were canceled.
Summary of Employee Stock Option Activity

A summary of the Company’s activity related to issuances of options to the Company’s employees, executives, directors and consultants and related information for the six months ended June 30, 2018 and the fiscal year ended December 31, 2017 is as follows:

 

   

For the six month period ended

June 30, 2018

    

For the year ended

December 31, 2017

  
    Amount of options     Weighted average exercise price     Aggregate intrinsic value     Amount of options     Weighted average exercise price     Aggregate intrinsic value  
          $     $           $     $  
Outstanding at beginning of year     62,500       0.01               4,193,397       0.11          
Granted                                                
Exercised     (62,500 )     0.01               -       -          
Cancelled     -       -               (4,130,397 )     (0.11 )        
                                                 
Outstanding at the end of period     -       -               62,500       0.01          
Vested and expected-to-vest at end of period     -       -       -       62,500       0.01       -  
Schedule of Stock Options Outstanding Exercise Price Range

The stock options outstanding as of June 30, 2018, and December 31, 2017, have been separated into exercise prices, as follows:

 

Exercise price   Stock options outstanding
as of		     Weighted average remaining contractual life – years as of     Stock options exercisable
as of		  
    June 30,
2018		     December 31, 2017     June 30,
2018		     December 31, 2017     June 30,
2018		     December 31, 2017  
                                     
0.01     -       62,500       -       8.25       -       62,500  
0.01     -       62,500       -       8.25       -       62,500